Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:56 pm Sale |
2024-09-30 | 13G | Artiva Biotherapeutics, Inc. ARTV |
venBio Global Strategic Fund III L.P. | 1,519,971 6.300% |
-298,624 (-16.42%) |
Filing History |
| 2024-08-08 9:05 pm Sale |
2024-08-08 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 2,031,920 3.400% |
-505,851 (-19.93%) |
Filing History |
| 2024-08-01 7:00 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
venBio Global Strategic Fund III L.P. | 1,818,595 7.800% |
1,818,595 (New Position) |
Filing History |
| 2024-02-09 4:38 pm Purchase |
2023-12-31 | 13G | RayzeBio, Inc. Common Stock RYZB |
venBio Global Strategic Fund III L.P. | 5,158,162 8.500% |
5,158,162 (New Position) |
Filing History |
| 2024-01-24 6:41 pm Purchase |
2023-12-06 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 4,382,504 8.400% |
117,832 (+2.76%) |
Filing History |
| 2023-06-21 4:33 pm Purchase |
2023-06-16 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 4,264,672 10.400% |
1,963,221 (+85.30%) |
Filing History |
| 2023-06-15 4:30 pm Purchase |
2023-06-13 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 2,537,771 6.100% |
671,432 (+35.98%) |
Filing History |
| 2023-01-30 5:25 pm Sale |
2023-01-27 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 2,720,994 4.800% |
-749,502 (-21.60%) |
Filing History |
| 2022-12-15 5:00 pm Sale |
2022-12-13 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 3,470,496 6.100% |
-1,541,040 (-30.75%) |
Filing History |
| 2022-09-26 4:24 pm Sale |
2021-02-09 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 2,301,451 6.900% |
-1,859 (-0.08%) |
Filing History |
| 2022-09-26 4:21 pm Unchanged |
2021-06-29 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 1,866,339 8.000% |
0 (Unchanged) |
Filing History |
| 2022-09-26 4:18 pm Sale |
2022-01-11 | 13G | CinCor Pharma, Inc. CINC |
venBio Global Strategic Fund III L.P. | 1,862,256 4.900% |
-118,450 (-5.98%) |
Filing History |
| 2022-09-14 5:01 pm Unchanged |
2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 5,011,536 9.950% |
0 (Unchanged) |
Filing History |
| 2022-05-27 5:26 pm Sale |
2022-05-25 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 1,866,339 8.030% |
-741,828 (-28.44%) |
Filing History |
| 2022-01-11 4:46 pm Purchase |
2022-01-11 | 13G | CinCor Pharma, Inc. CINC |
venBio Global Strategic Fund III L.P. | 1,980,706 5.600% |
1,980,706 (New Position) |
Filing History |
| 2021-11-04 4:15 pm Purchase |
2021-10-25 | 13D | Ventyx Biosciences, Inc. VTYX |
venBio Global Strategic Fund III L.P. | 5,011,536 9.950% |
5,011,536 (New Position) |
Filing History |
| 2021-07-09 4:01 pm Purchase |
2021-06-29 | 13D | Elevation Oncology, Inc. ELEV |
venBio Global Strategic Fund III L.P. | 2,608,167 11.430% |
2,608,167 (New Position) |
Filing History |
| 2021-02-19 4:49 pm Purchase |
2021-02-09 | 13D | Pharvaris N.V. PHVS |
venBio Global Strategic Fund III L.P. | 2,303,310 7.000% |
2,303,310 (New Position) |
Filing History |